FANCI and melanoma: In the case of the two novel VUS variants we identified in the FANCI gene, we were unable to establish any disease-modifying role based on the available clinical data of our patients, so further studies and careful follow-up of these patients are needed to determine their role in melanoma disease progression and therapeutic response.